[1]
E. Wójcik, J. Kufel-Grabowska, and J. Gierba-Tomczyk, “Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy”, OncoReview, vol. 7, no. 4(28), pp. 162-167, Dec. 2017.